ArticleNeuro-oncology advances

Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy.

Roei D Mazor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.